These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3157585)

  • 61. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.
    Leysen JE; Awouters F; Kennis L; Laduron PM; Vandenberk J; Janssen PA
    Life Sci; 1981 Mar; 28(9):1015-22. PubMed ID: 6261070
    [No Abstract]   [Full Text] [Related]  

  • 62. Variations in binding of [3H]5-HT to cortical membranes during the female rat estrous cycle.
    Uphouse L; Williams J; Eckols K; Sierra V
    Brain Res; 1986 Sep; 381(2):376-81. PubMed ID: 3756512
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacological characterization of the 5-HT1A, 5-HT2 and 5-HT3 receptors in the bovine ciliary muscle.
    Lograno MD; Romano MR
    Eur J Pharmacol; 2003 Mar; 464(1):69-74. PubMed ID: 12600697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modulation of brain S2 serotonin receptors by lithium, sodium and potassium chloride.
    Battaglia G; Shannon M; Titeler M
    Life Sci; 1983 May; 32(22):2597-601. PubMed ID: 6304441
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).
    Shannon M; Battaglia G; Glennon RA; Titeler M
    Eur J Pharmacol; 1984 Jun; 102(1):23-9. PubMed ID: 6479216
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Solubilized serotonin receptors from rat and dog brain. Selective labelling with [3H]ketanserin.
    Ilien B; Schotte A; Laduron PM
    FEBS Lett; 1982 Feb; 138(2):311-5. PubMed ID: 6121721
    [No Abstract]   [Full Text] [Related]  

  • 68. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
    Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
    J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of non-serotonergic [3H]ketanserin binding sites on human platelets and their role in serotonin release.
    Leysen JE; Gommeren W; Janssen PA
    Eur J Pharmacol; 1991 Jan; 206(1):39-45. PubMed ID: 2065715
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
    Killam AL; Nikam SS; Lambert GM; Martin AR; Nelson DL
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1083-9. PubMed ID: 2319460
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differences in ketanserin binding in the ventromedial hypothalamus of ewes responsive or refractory to short days.
    Le Corre S; Segu L; Caldani M; Chemineau P
    Neuroendocrinology; 1994 Dec; 60(6):589-600. PubMed ID: 7700502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
    Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression.
    Edwards E; Harkins K; Wright G; Henn F
    J Neurochem; 1991 May; 56(5):1581-6. PubMed ID: 1826517
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization and regional distribution of serotonin S2-receptors in human brain.
    Schotte A; Maloteaux JM; Laduron PM
    Brain Res; 1983 Oct; 276(2):231-5. PubMed ID: 6627007
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [3H]-ketanserin binding sites in different psychiatric disorders.
    Marazziti D; Giannaccini G; Giromella A; Betti L; Pesce D; Nardi I; Rossi A; Lucacchini A; Cassano GB
    Neurochem Int; 2003 May; 42(6):511-6. PubMed ID: 12547650
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [3H]-ketanserin binding and elevated plus-maze behavior after chronic antidepressant treatment in DSP-4 and P-CPA pretreated rats: evidence for partial involvement of 5-HT2A receptors.
    Skrebuhhova T; Allikmets L; Matto V
    Methods Find Exp Clin Pharmacol; 1999 Sep; 21(7):483-90. PubMed ID: 10544393
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhancement of [m-methoxy 3H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats.
    Jackson J; Paulose CS
    Mol Cell Biochem; 1999 Sep; 199(1-2):81-5. PubMed ID: 10544955
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analysis of binding of [3H]Estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus.
    Boctor AM; Band P; Grossman A
    Endocrinology; 1983 Aug; 113(2):453-62. PubMed ID: 6872936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.